In silico design of peptide inhibitors of tubulin: amyloid-β as a lead compound

References

• Ari, C., Borysov, S. I., Wu, J., Padmanabhan, J., & Potter, H. (2014). Alzheimer amyloid beta inhibition of Eg5/kinesin 5 reduces neurotrophin and/or transmitter receptor function. Neurobiology of Aging, 35(8), 1839–1849. doi:10.1016/j.neurobiolaging.2014.02.006
   PubMed Web of Science ®Google Scholar
• Bai, R. L., Pettit, G. R., & Hamel, E. (1990). Binding of dolastatin 10 to tubulin at a distinct site for peptide antimitotic agents near the exchangeable nucleotide and vinca alkaloid sites. Journal of Biological Chemistry, 265(28), 17141–17149.
   PubMed Web of Science ®Google Scholar
• Behrens, M. I., Lendon, C., & Roe, C. M. (2009). A common biological mechanism in cancer and Alzheimer’s disease? Current Alzheimer Research, 6(3), 196–204. doi:10.2174/156720509788486608
   PubMed Web of Science ®Google Scholar
• Bornens, M. (2012). The centrosome in cells and organisms. Science (New York, N.Y.), 335(6067), 422–426. doi:10.1126/science.1209037
   PubMed Web of Science ®Google Scholar
• Borysov, S. I., Granic, A., Padmanabhan, J., Walczak, C. E., & Potter, H. (2011). Alzheimer Aβ disrupts the mitotic spindle and directly inhibits mitotic microtubule motors. Cell Cycle (Georgetown, Tex.), 10(9), 1397–1410. doi:10.4161/cc.10.9.15478
   PubMed Web of Science ®Google Scholar
• Bussi, G., Donadio, D., & Parrinello, M. (2007). Canonical sampling through velocity rescaling. The Journal of Chemical Physics, 126(1), 014101. doi:10.1063/1.2408420
   PubMed Web of Science ®Google Scholar
• Cormier, A., Marchand, M., Ravelli, R. B., Knossow, M., & Gigant, B. (2008). Structural insight into the inhibition of tubulin by vinca domain peptide ligands. EMBO Reports, 9(11), 1101–1106. doi:10.1038/embor.2008.171
   PubMed Web of Science ®Google Scholar
• Di, L. (2015). Strategic approaches to optimizing peptide ADME properties. The AAPS Journal, 17(1), 134–143. doi:10.1208/s12248-014-9687-3
   PubMed Web of Science ®Google Scholar
• Du, S., Zhang, K., Yao, X., & Du, J. (2019). Investigation on the fungicide resistance mechanism against Botrytis cinerea β-tubulin inhibitor zoxamide by computational study. Journal of Biomolecular Structure and Dynamics, 1–9. doi:10.1080/07391102.2019.1671230
   Web of Science ®Google Scholar
• Dumontet, C., & Jordan, M. A. (2010). Microtubule-binding agents: A dynamic field of cancer therapeutics. Nature Reviews Drug Discovery, 9(10), 790–803. doi:10.1038/nrd3253
   PubMed Web of Science ®Google Scholar
• Ebadi, A., Razzaghi-Asl, N., Khoshneviszadeh, M., & Miri, R. (2013). Comparative amino acid decomposition analysis of potent type I p38α inhibitors. Daru: Journal of Faculty of Pharmacy, Tehran University of Medical Sciences, 21(1), 41. doi:10.1186/2008-2231-21-41
   PubMed Web of Science ®Google Scholar
• Ganguli, M., Dodge, H. H., Shen, C., Pandav, R. S., & DeKosky, S. T. (2005). Alzheimer disease and mortality: A 15-year epidemiological study. Archives of Neurology, 62(5), 779–784. doi:10.1001/archneur.62.5.779
   PubMedGoogle Scholar
• Gigant, B., Wang, C., Ravelli, R. B. G., Roussi, F., Steinmetz, M. O., Curmi, P. A., Sobel, A., & Knossow, M. (2005). Structural basis for the regulation of tubulin by vinblastine. Nature, 435(7041), 519–522. doi:10.1038/nature03566
   PubMed Web of Science ®Google Scholar
• Hamel, E. (2002). Interactions of antimitotic peptides and depsipeptides with tubulin. Biopolymers, 66(3), 142–160. doi:10.1002/bip.10255
   PubMed Web of Science ®Google Scholar
• Hamel, E., & Covell, D. G. (2002). Antimitotic peptides and depsipeptides. Current Medicinal Chemistry-anti-Cancer Agents, 2(1), 19–53. doi:10.2174/1568011023354263
   PubMedGoogle Scholar
• Hardy, J., & Selkoe, D. J. (2002). The amyloid hypothesis of Alzheimer’s disease: Progress and problems on the road to therapeutics. Science, 297(5580), 353–356. doi:10.1126/science.1072994
   PubMed Web of Science ®Google Scholar
• Hess, B., Kutzner, C., Van Der Spoel, D., & Lindahl, E. (2008). GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation. Journal of Chemical Theory and Computation, 4(3), 435–447. doi:10.1021/ct700301q
   PubMed Web of Science ®Google Scholar
• Jana, S., & Singh, S. K. (2020). Identification of human tau-tubulin kinase 1 inhibitors: An integrated e-pharmacophore-based virtual screening and molecular dynamics simulation. Journal of Biomolecular Structure & Dynamics, 38(3), 886–900. doi:10.1080/07391102.2019.1590242
   PubMed Web of Science ®Google Scholar
• Kaspar, A. A., & Reichert, J. M. (2013). Future directions for peptide therapeutics development. Drug Discovery Today, 18(17–18), 807–817. doi:10.1016/j.drudis.2013.05.011
   PubMed Web of Science ®Google Scholar
• Kortemme, T., & Baker, D. (2002). A simple physical model for binding energy hot spots in protein–protein complexes. Proceedings of the National Academy of Sciences of United States of America, 99(22), 14116–14121. doi:10.1073/pnas.202485799
   PubMed Web of Science ®Google Scholar
• Kueh, H. Y., & Mitchison, T. J. (2009). Structural plasticity in actin and tubulin polymer dynamics. Science (New York, N.Y.), 325(5943), 960–963. doi:10.1126/science.1168823
   PubMed Web of Science ®Google Scholar
• Kumbhar, B. V., Bhandare, V. V., Panda, D., & Kunwar, A. (2020). Delineating the interaction of combretastatin A-4 with αβ tubulin isotypes present in drug resistant human lung carcinoma using a molecular modeling approach. Journal of Biomolecular Structure & Dynamics, 38(2), 426–438. doi:10.1080/07391102.2019.1577174
   PubMed Web of Science ®Google Scholar
• Kyte, J., & Doolittle, R. F. (1982). A simple method for displaying the hydropathic character of a protein. Journal of Molecular Biology, 157(1), 105–132. doi:10.1016/0022-2836(82)90515-0
   PubMed Web of Science ®Google Scholar
• Laskowski, R. A. (2009). PDBsum new things. Nucleic Acids Research, 37(Database issue), D355–D359. doi:10.1093/nar/gkn860
   PubMed Web of Science ®Google Scholar
• Lau, J. L., & Dunn, M. K. (2018). Therapeutic peptides: Historical perspectives, current development trends, and future directions. Bioorganic & Medicinal Chemistry, 26(10), 2700–2707. doi:10.1016/j.bmc.2017.06.052
   PubMed Web of Science ®Google Scholar
• Lee, S. K., Chang, G. S., Lee, I. H., Chung, J. E., Sung, K. Y., & No, K. T. (2004). The PreADME: Pc-based program for batch prediction of adme properties. EuroQSAR, 9, 5–10.
   Google Scholar
• Löwe, J., Li, H., Downing, K. H., & Nogales, E. (2001). Refined structure of αβ-tubulin at 3.5 Å resolution1. Journal of Molecular Biology, 313(5), 1045–1057. doi:10.1006/jmbi.2001.5077
   PubMed Web of Science ®Google Scholar
• Marrink, S. J., Risselada, H. J., Yefimov, S., Tieleman, D. P., & De Vries, A. H. (2007). The MARTINI force field: Coarse grained model for biomolecular simulations. The Journal of Physical Chemistry. B, 111(27), 7812–7824. doi:10.1021/jp071097f
   PubMed Web of Science ®Google Scholar
• Mitchison, T., & Kirschner, M. (1984). Dynamic instability of microtubule growth. Nature, 312(5991), 237–242. doi:10.1038/312237a0
   PubMed Web of Science ®Google Scholar
• Nogales, E., Downing, K. H., Amos, L. A., & Löwe, J. (1998). Tubulin and FtsZ form a distinct family of GTPases. Nature Structural Biology, 5(6), 451–458. doi:10.1038/nsb0698-451
   PubMedGoogle Scholar
• Oostenbrink, C., Villa, A., Mark, A. E., & Van Gunsteren, W. F. (2004). A biomolecular force field based on the free enthalpy of hydration and solvation: The GROMOS force-field parameter sets 53A5 and 53A6 . Journal of Computational Chemistry, 25(13), 1656–1676. doi:10.1002/jcc.20090
   PubMed Web of Science ®Google Scholar
• Paris, D., Townsend, K., Quadros, A., Humphrey, J., Sun, J., Brem, S., Wotoczek-Obadia, M., DelleDonne, A., Patel, N., Obregon, D. F., Crescentini, R., Abdullah, L., Coppola, D., Rojiani, A. M., Crawford, F., Sebti, S. M., & Mullan, M. (2004). Inhibition of angiogenesis by Aβ peptides. Angiogenesis, 7(1), 75–85. doi:10.1023/B:AGEN.0000037335.17717.bf
   PubMedGoogle Scholar
• Parrinello, M., & Rahman, A. (1981). Polymorphic transitions in single crystals: A new molecular dynamics method. Journal of Applied Physics, 52(12), 7182–7190. doi:10.1063/1.328693
   Web of Science ®Google Scholar
• Periole, X., Cavalli, M., Marrink, S.-J., & Ceruso, M. A. (2009). Combining an elastic network with a coarse-grained molecular force field: Structure, dynamics, and intermolecular recognition. Journal of Chemical Theory and Computation, 5(9), 2531–2543. doi:10.1021/ct9002114
   PubMed Web of Science ®Google Scholar
• Pires, D. E., Blundell, T. L., & Ascher, D. B. (2015). pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. Journal of Medicinal Chemistry, 58(9), 4066–4072. doi:10.1021/acs.jmedchem.5b00104
   PubMed Web of Science ®Google Scholar
• Porollo, A., & Meller, J. (2006). Prediction‐based fingerprints of protein–protein interactions. Proteins: Structure, Function, and Bioinformatics, 66(3), 630–645. doi:10.1002/prot.21248
   Web of Science ®Google Scholar
• Räder, A. F., Reichart, F., Weinmüller, M., & Kessler, H. (2018). Improving oral bioavailability of cyclic peptides by N-methylation. Bioorganic & Medicinal Chemistry, 26(10), 2766–2773. doi:10.1016/j.bmc.2017.08.031
   PubMed Web of Science ®Google Scholar
• Ravelli, R. B. G., Gigant, B., Curmi, P. A., Jourdain, I., Lachkar, S., Sobel, A., & Knossow, M. (2004). Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain. Nature, 428(6979), 198–202.
   PubMed Web of Science ®Google Scholar
• Razzaghi-Asl, N., Karimi, A., & Ebadi, A. (2018). The potential of natural product vs neurodegenerative disorders: In silico study of artoflavanocoumarin as BACE-1 inhibitor. Computational Biology and Chemistry, 77, 307–317. doi:10.1016/j.compbiolchem.2018.10.015
   PubMed Web of Science ®Google Scholar
• Saha, A., Mohapatra, S., Kurkute, P., Jana, B., Mondal, P., Bhunia, D., Ghosh, S., & Ghosh, S. (2015). Interaction of Aβ peptide with tubulin causes an inhibition of tubulin polymerization and the apoptotic death of cancer cells. Chemical Communications (Communications), 51(12), 2249–2252. doi:10.1039/C4CC09390A
   PubMed Web of Science ®Google Scholar
• Smith, C. D., & Zhang, X. (1996). Mechanism of action of cryptophycin interaction with the vinca alkaloid domain of tubulin. The Journal of Biological Chemistry, 271(11), 6192–6198. doi:10.1074/jbc.271.11.6192
   PubMed Web of Science ®Google Scholar
• Sponne, I., Fifre, A., Drouet, B., Klein, C., Koziel, V., Pinçon-Raymond, M., Olivier, J.-L., Chambaz, J., & Pillot, T. (2003). Apoptotic neuronal cell death induced by the non-fibrillar amyloid-β peptide proceeds through an early reactive oxygen species-dependent cytoskeleton perturbation. The Journal of Biological Chemistry, 278(5), 3437–3445. doi:10.1074/jbc.M206745200
   PubMed Web of Science ®Google Scholar
• van Zundert, G. C. P., Rodrigues, J. P. G. L. M., Trellet, M., Schmitz, C., Kastritis, P. L., Karaca, E., Melquiond, A. S. J., van Dijk, M., de Vries, S. J., & Bonvin, A. M. J. J. (2016). The HADDOCK2. 2 web server: User-friendly integrative modeling of biomolecular complexes. Journal of Molecular Biology, 428(4), 720–725. doi:10.1016/j.jmb.2015.09.014
   PubMed Web of Science ®Google Scholar
• Vivekanandan, S., Brender, J. R., Lee, S. Y., & Ramamoorthy, A. (2011). A partially folded structure of amyloid-beta (1–40) in an aqueous environment. Biochemical and Biophysical Research Communications, 411(2), 312–316. doi:10.1016/j.bbrc.2011.06.133
   PubMed Web of Science ®Google Scholar
• Waight, A. B., Bargsten, K., Doronina, S., Steinmetz, M. O., Sussman, D., & Prota, A. E. (2016). Structural basis of microtubule destabilization by potent auristatin anti-mitotics. PLoS One, 11(8), e0160890doi:10.1371/journal.pone.0160890
   PubMed Web of Science ®Google Scholar
• Werle, M., & Föger, F. (2018). Peroral peptide delivery: Peptidase inhibition as a key concept for commercial drug products. Bioorganic & Medicinal Chemistry, 26(10), 2906–2913. doi:10.1016/j.bmc.2017.08.028
   PubMed Web of Science ®Google Scholar
• Yamada, M., Sasaki, H., Mimori, Y., Kasagi, F., Sudoh, S., Ikeda, J., Hosoda, Y., Nakamura, S., & Kodama, K. (1999). Prevalence and risks of dementia in the Japanese population: RERF’s adult health study Hiroshima subjects. Journal of the American Geriatrics Society, 47(2), 189–195. doi:10.1111/j.1532-5415.1999.tb04577.x
   PubMed Web of Science ®Google Scholar